Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type

Journal of Clinical Microbiology

Volumn 47, Issue 3, 2009, Pages 680-688

  Litt, David J ^a   Neal, Shona E ^a   Fry, Norman K ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; UNITED KINGDOM; VACCINATION;

BACTERIAL TYPING TECHNIQUES; BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; GENETIC VARIATION; GENOTYPE; GREAT BRITAIN; HUMANS; INFANT; PERTUSSIS VACCINE; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA; VIRULENCE FACTORS; WHOOPING COUGH;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

EID: 62749186122     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01838-08     Document Type: Article

References (42)

1. Advani, A., D. Donnelly, L. Gustafsson, and H. O. Hallander. 2007. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004. APMIS 115:299-310.
2. Advani, A., L. Gustafsson, R.-M. Carlsson, D. Donnelly, and H. O. Hallander. 2007. Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype. APMIS 115:736-742.
3. Borisova, O., S. Yu Kombarova, N. S. Zakharova, M. van Gent, V. A. Aleshkin, I. Mazurova, and F. R. Mooi. 2007. Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin. Vaccine Immunol. 14:234-238.
4. Caro, V., A. Elomaa, D. Brun, J. Mertsola, Q. He, and N. Guiso. 2006. Bordetella pertussis, Finland and France. Emerg. Infect. Dis. 12:987-989.
5. Caro, V., E. Njamkepo, S. C. M. Van Amersfoorth, F. R. Mooi, A. Advani, H. O. Hallander, Q. He, J. Mertsola, M. Riffelmann, C. Vahrenholz, C. H. W. von König, and N. Guiso. 2005. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect. 7:976-982.
6. Cassiday, P., G. Sanden, K. Heuvelman, F. Mooi, K. M. Bisgard, and T. Popovic. 2000. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J. Infect. Dis. 182:1402-1408.
7. Celentano, L. P., M. Massari, D. Paramatti, S. Salmaso, and A. E. Tozzi. 2005. Resurgence of pertussis in Europe. Pediatr. Infect. Dis. J. 24:761-765.
8. Chief Medical Officer. 2001. Current vaccine and immunisation issues. Letter PL CMO (2001)5. United Kingdom Department of Health, London, United Kingdom.
9. Chief Medical Officer. 2004. New vaccinations for the childhood immunisation programme. Letter PL CMO (2004)3. United Kingdom Department of Health, London, United Kingdom.
10. Crowcroft, N. S., R. Booy, T. Harrison, L. Spicer, J. Britto, Q. Mok, P. Heath, I. Murdoch, M. Zambon, R. George, and E. Miller. 2003. Severe and unrecognised: pertussis in UK infants. Arch. Dis. Child. 88:802-806.
11. Elomaa, A., A. Advani, D. Donnelly, M. Antila, J. Mertsola, H. Hallander, and Q. He. 2005. Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J. Clin. Microbiol. 43:3681-3687.
12. Elomaa, A., A. Advani, D. Donnelly, M. Antila, J. Mertsola, Q. He, and H. Hallander. 2007. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine 25:918-926.
13. Fry, N. K., S. Neal, T. G. Harrison, E. Miller, R. Matthews, and R. C. George. 2001. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect. Immun. 69:5520-5528.
14. Grant, C. C., and J. D. Cherry. 2002. Keeping pace with the elusive Bordetella pertussis. J. Infect. 44:7-12.
15. Gzyl, A., E. Augustynowicz, I. van Loo, and J. Slusarczyk. 2001. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 20:299-303.
16. Hallander, H., A. Advani, M. Riffelmann, C. H. W. von König, V. Caro, N. Guiso, F. R. Mooi, A. Gzyl, M. S. Kaltoft, N. K. Fry, J. Mertsola, and Q. He. 2007. Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J. Clin. Microbiol. 45:3257-3262.
17. Hallander, H. O., A. Advani, D. Donnelly, L. Gustafsson, and R.-M. Carlsson. 2005. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J. Clin. Microbiol. 43:2856-2865.
18. Harrison, T. G., and A. G. Taylor. 1988. A laboratory manual for Legionella, p. 157-158. John Wiley and Sons, Ltd., Chichester, United Kingdom.
19. Hunter, P. R., and M. A. Gaston. 1988. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 26:2465-2466.
20. King, A. J., T. van Gorkom, J. L. A. Pennings, H. G. J. van der Heide, Q. He, D. Diavatopoulos, K. Heuvelman, M. van Gent, K. van Leeuwen, and F. R. Mooi. 2008. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics 9:311.
21. Kourova, N., V. Caro, C. Weber, S. Thiberge, R. Chuprinina, G. Tseneva, and N. Guiso. 2003. Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains. J. Clin. Microbiol. 41:3706-3711.
22. Lin, Y.-C., S.-M. Yao, J.-J. Yan, Y.-Y. Chen, M.-J. Hsiao, C.-Y. Chou, H.-P. Su, H.-S. Wu, and S.-Y. Li. 2006. Molecular epidemiology of Bordetella pertussis in Taiwan, 1993-2004: suggests one possible explanation for the outbreak of pertussis in 1997. Microbes Infect. 8:2082-2087.
23. Mastrantonio, P., P. Spigaglia, H. van Oirschot, H. G. J. van der Heide, K. Heuvelman, P. Stefanelli, and F. R. Mooi. 1999. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 145:2069-2075.
24. Miller, E., J. E. Vurdien, and J. M. White. 1992. The epidemiology of pertussis in England and Wales. Commun. Dis. Rep. CDR Rev. 2:R152-R154.
25. Mooi, F. R., H. Hallander, C. H. Wirsing von König, B. Hoet, and N. Guiso. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 19:174-181.
26. Mooi, F. R., Q. He, H. van Oirschot, and J. Mertsola. 1999. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect. Immun. 67:3133-3134.
27. Mooi, F. R., H. van Oirschot, K. Heuvelman, H. G. J. van der Heide, W. Gaastra, and R. J. L. Willems. 1998. Polymorphism in the Bordetella pertussis virulence factors P. 69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66:670-675.
28. Ntezayabo, B., G. De Serres, and B. Duval. 2003. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr. Infect. Dis. J. 22:22-27.
29. Packard, E. R., R. Parton, J. G. Coote, and N. K. Fry. 2004. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J. Med. Microbiol. 53:355-365.
30. Poynten, M., P. B. McIntyre, F. R. Mooi, K. J. Heuvelman, and G. L. Gilbert. 2004. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol. Infect. 132:185-193.
31. Preston, N. W., and E. J. Carter. 1992. Serotype specificity of vaccineinduced immunity to pertussis. Commun. Dis. Rep. CDR Rev. 2:R155-R156.
32. Schouls, L. M., H. G. J. van der Heide, L. Vauterin, P. Vauterin, and F. R. Mooi. 2004. Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J. Bacteriol. 186:5496-5505.
33. Simpson, E. H. 1949. Measurement of diversity. Nature 163:688.
34. Tanaka, M., C. R. Vitek, F. B. Pascual, K. M. Bisgard, J. E. Tate, and T. V. Murphy. 2003. Trends in pertussis among infants in the United States, 1980-1999. JAMA 290:2968-2975.
35. Tsang, R. S., A. K. H. Lau, M. L. Sill, S. A. Halperin, P. Van Caeseele, F. Jamieson, and I. E. Martin. 2004. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J. Clin. Microbiol. 42:5364-5367.
36. Tsang, R. S., M. L. Sill, I. E. Martin, and F. Jamieson. 2005. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine. Can. J. Microbiol. 51:887-892.
37. van Amersfoorth, S. C. M., L. M. Schouls, H. G. J. van der Heide, A. Advani, H. O. Hallander, K. Bondeson, C. H. W. von König, M. Riffelmann, C. Vahrenholz, N. Guiso, V. Caro, E. Njamkepo, Q. He, J. Mertsola, and F. R. Mooi. 2005. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol. 43:2837-2843.
38. van Buynder, P. G., D. Owen, J. E. Vurdien, N. J. Andrews, R. C. Matthews, and E. Miller. 1999. Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol. Infect. 123:403-411.
39. van Loo, I. H., H. G. van der Heide, N. J. Nagelkerke, J. Verhoef, and F. R. Mooi. 1999. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J. Infect. Dis. 179:915-923.
40. van Loo, I. H. M., K. J. Heuvelman, A. J. King, and F. R. Mooi. 2002. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J. Clin. Microbiol. 40:1994-2001.
41. Van Loo, I. H. M., and F. R. Mooi. 2002. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology 148:2011-2018.
42. Weber, C., C. Boursaux-Eude, G. Coralie, V. Caro, and N. Guiso. 2001. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol. 39:4396-4403.